Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes

British Journal of Pharmacology

Volumn 117, Issue 7, 1996, Pages 1381-1386

  Zocchi, Cristina ^a   Ongini, Ennio ^a   Ferrara, Silvia ^a   Baraldi, Pier Giovanni ^b   Dionisotti, Silvio ^a  

^a San Raffaele Science Park   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

A2A receptor antagonists; Adenosine receptors; CGS 21680; Non xanthine adenosine receptor antagonists; SCH 58261

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 7 (2 PHENYLETHYL) 2 (2 FURYL) PYRAZOLO(4,3E) 1,2,4 TRIAZOLO(1,5C) PYRIMIDINE; 8 (3,4 DIMETHOXYSTYRYL) 7 METHYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLOHEXYLADENOSINE; GUANOSINE TRIPHOSPHATE; PHENYLISOPROPYLADENOSINE; PYRIMIDINE DERIVATIVE; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; 9 CHLORO 2 (2 FURYL) (1,2,4)TRIAZOLO(1,5 C)QUINAZOLIN 5 IMINE; 9-CHLORO-2-(2-FURYL)-(1,2,4)TRIAZOLO(1,5-C)QUINAZOLIN-5-IMINE; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE; QUINAZOLINE DERIVATIVE; TRIAZOLE DERIVATIVE; TRITIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; DRUG SELECTIVITY; MALE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STEREOCHEMISTRY; ANIMAL; BINDING COMPETITION; DRUG ANTAGONISM; DRUG POTENTIATION; IN VITRO STUDY; KINETICS; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT;

ADENOSINE; ANIMALS; BINDING, COMPETITIVE; CORPUS STRIATUM; KINETICS; MALE; PYRIMIDINES; QUINAZOLINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; TRIAZOLES; TRITIUM;

EID: 0029670309     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15296.x     Document Type: Article

References (34)

1. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett., 4, 2539-2544.
2. 2 receptors. Naunyn-Schmied. Arch. Pharmacol., 335, 64-69.
3. 3H]NECA in rat striatal membranes. Mol. Pharmacol., 29, 331-346.
4. COLLIS, M.G. & HOURANI, S.M.O. (1993). Adenosine receptor subtypes. Trends Pharmacol. Sci., 14, 360-366.
5. 2 adenosine receptors. J. Med. Chem., 35, 2363-2368.
6. 2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models. Br. J. Pharmacol., 112, 659-665.
7. DIONISOTTI, S., ZOCCHI, C., VARANI, K., BOREA, P.A. & ONGINI, E. (1992). Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn-Schmied. Arch. Pharmacol., 346, 673-676.
8. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
9. 2 adenosine receptor antagonists. Eur. J. Med. Chem., 28, 569-577.
10. GILMAN, A.G. (1987). G-proteins: transducer of receptor-generated signals. Annu. Rev. Biochem., 56, 615-649.
11. 2-selective adenosine antagonists. J. Med. Chem., 36, 1333-1342.
12. 2 receptors in rat brain. J. Pharmacol. Exp. Ther., 251, 888-893.
13. 1 receptor in the rat cortex. Mol. Pharmacol., 39, 49-54.
14. 2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Recept. Res., 12, 149-169.
15. 2 receptors in rat striatum. Biochem. Pharmacol., 44, 2365-2370.
16. 3H]-CGS 21680 binding sites in the rat striatum and cortex. Br. J. Pharmacol., 114, 537-543.
17. 1 adenosine receptors of rat brain. J. Neurochem., 54, 1988-1994.
18. LONDOS, C., COOPER, D.M.F. & WOLFF, J. (1980). Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. U.S.A., 77, 2551-2554.
19. LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.I. & RANDALL, R.J. (1951). Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
20. 125I]iodophenyl)ethylamino] adenosine. Mol. Pharmacol., 47, 307-313.
21. MUNSON, P.J. & RODBARD, P. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220-239.
22. 2 adenosine receptor: guanine nucleolide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol., 39, 130-135.
23. 2-adenosine receptor. J. Recept. Res., 13, 961-973.
24. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol., 46, 817-822.
25. 2 antagonist, (E)-1,3-dipropyl-8-(3,4-dimethoxy-styryl)-7-methylxanthine. J. Med. Chem., 36, 3731-3733.
26. 1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein. J. Pharmacol. Exp. Ther., 246, 1194-1200.
27. SCHIEMANN, W.P., WALTHER, J.M. & BUXTON, I.L.O. (1990). On the ability of endogenous adenosine to regulate purine nucleoside receptor binding of antagonists in smooth muscle membranes. J. Pharmacol. Exp. Ther., 255, 886-892.
28. 2 antagonists. J. Med. Chem., 35, 2342-2345.
29. STILES, G.L. & JACOBSON, K.A. (1987). A new affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe. Mol. Pharmacol., 32, 184-188.
30. VAN CALKER, D., MULLER, M. & HAMPRECHT, B. (1979). Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 33, 999-1005.
31. WILLIAMS, M., FRANCIS, J., GHAI, G., BRAUNWALDER, A., PSYCHOYOS, S., STONE, G.A. & CASH, W.D. (1987). Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel non-xanthine adenosine antagonist. J. Pharmacol. Exp. Ther., 241, 415-420.
32. 3H]5′-N-ethylcarboxamidoadenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn-Schmied. Arch. Pharmacol., 325, 218-225.
33. 2A receptor antagonist. Br. J. Pharmacol., 114, 299P.
34. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther., (in press).